Simplified management protocol for term neonates after prolonged rupture of membranes in a setting with high rates of neonatal sepsis and mortality: a quality improvement study

Arch Dis Child. 2019 Feb;104(2):115-120. doi: 10.1136/archdischild-2018-315826. Epub 2018 Nov 24.

Abstract

In low-income and middle-income countries, courses of antibiotics are routinely given to term newborns whose mothers had prolonged rupture of membranes (PROM). Rational antibiotic use is vital given rising rates of antimicrobial resistance and potential adverse effects of antibiotic exposure in newborns. However missing cases of sepsis can be life-threatening.This is a quality improvement evaluation of a protocol for minimal or no antibiotics in term babies born after PROM in Papua New Guinea. Asymptomatic, term babies born to women with PROM >12 hours prior to birth were given a stat dose of antibiotics, or no antibiotics if the mother had received intrapartum antibiotics, reviewed and discharged at 48-72 hours with follow-up. Clinical signs of sepsis within the first week and the neonatal period were assessed. Of 170 newborns whose mothers had PROM, 133 were assessed at 7 days: signs of sepsis occurred in 10 babies (7.5%; 95% CI 4.4% to 13.2%) in the first week. Five had isolated fever, four had skin pustules and one had fever with periumbilical erythema. An additional four (3%) had any sign of sepsis between 8 and 28 days. There was one case of bacteraemia and no deaths. 37 were lost to follow-up, but hospital records did not identify any subsequent admissions for infection. A rate of sepsis was documented that was comparable with other studies in low-income countries. This protocol may reduce antimicrobial resistance and consequences of antibiotic exposure in newborns, provided safeguards are in place to monitor for signs of sepsis.

Keywords: antibiotic resistance; low and middle income country; neonatal sepsis; prolonged rupture of membranes; quality improvement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis*
  • Clinical Protocols
  • Developing Countries
  • Drug Resistance, Bacterial
  • Female
  • Fetal Membranes, Premature Rupture / drug therapy*
  • Follow-Up Studies
  • Gentamicins / therapeutic use
  • Humans
  • Infant, Newborn
  • Injections, Intramuscular
  • Male
  • Medical Overuse / prevention & control
  • Neonatal Sepsis / drug therapy*
  • Neonatal Sepsis / prevention & control*
  • Papua New Guinea / epidemiology
  • Pregnancy
  • Prenatal Care*
  • Prospective Studies
  • Quality Improvement
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Amoxicillin